Functional Insights into the Sphingolipids C1P, S1P, and SPC in Human Fibroblast-like Synoviocytes by Proteomic Analysis.
Thomas TimmChristiane HildGerhard LiebischMarkus RickertGuenter LochnitJuergen SteinmeyerPublished in: International journal of molecular sciences (2024)
The (patho)physiological function of the sphingolipids ceramide-1-phosphate (C1P), sphingosine-1-phosphate (S1P), and sphingosylphosphorylcholine (SPC) in articular joints during osteoarthritis (OA) is largely unknown. Therefore, we investigated the influence of these lipids on protein expression by fibroblast-like synoviocytes (FLSs) from OA knees. Cultured human FLSs ( n = 7) were treated with 1 of 3 lipid species-C1P, S1P, or SPC-IL-1β, or with vehicle. The expression of individual proteins was determined by tandem mass tag peptide labeling followed by high-resolution electrospray ionization (ESI) mass spectrometry after liquid chromatographic separation (LC-MS/MS/MS). The mRNA levels of selected proteins were analyzed using RT-PCR. The 3sphingolipids were quantified in the SF of 18 OA patients using LC-MS/MS. A total of 4930 proteins were determined using multiplex MS, of which 136, 9, 1, and 0 were regulated both reproducibly and significantly by IL-1β, C1P, S1P, and SPC, respectively. In the presence of IL-1ß, all 3 sphingolipids exerted ancillary effects. Only low SF levels of C1P and SPC were found. In conclusion, the 3 lipid species regulated proteins that have not been described in OA. Our results indicate that charged multivesicular body protein 1b, metal cation symporter ZIP14, glutamine-fructose-6-P transaminase, metallothionein-1F and -2A, ferritin, and prosaposin are particularly interesting proteins due to their potential to affect inflammatory, anabolic, catabolic, and apoptotic mechanisms.
Keyphrases
- ms ms
- mass spectrometry
- endothelial cells
- knee osteoarthritis
- high resolution
- end stage renal disease
- newly diagnosed
- cell death
- liquid chromatography
- chronic kidney disease
- poor prognosis
- fatty acid
- binding protein
- rheumatoid arthritis
- pluripotent stem cells
- ionic liquid
- risk assessment
- induced pluripotent stem cells
- high performance liquid chromatography
- liquid chromatography tandem mass spectrometry
- patient reported outcomes
- simultaneous determination
- climate change
- human health
- protein protein
- patient reported